key: cord-0864900-2jyi2lrk
authors: Vastrad, Basavaraj; Vastrad, Chanabasayya
title: Identification of biomarkers, pathways and potential therapeutic targets for heart failure using bioinformatics analysis
date: 2021-08-06
journal: bioRxiv
DOI: 10.1101/2021.08.05.455244
sha: 2238ec54ebded97a11d1a5598f2dff17e62d5e46
doc_id: 864900
cord_uid: 2jyi2lrk

Heart failure (HF) is a complex cardiovascular diseases associated with high mortality. To discover key molecular changes in HF, we analyzed next-generation sequencing (NGS) data of HF. In this investigation, differentially expressed genes (DEGs) were analyzed using limma in R package from GSE161472 of the Gene Expression Omnibus (GEO). Then, gene enrichment analysis, protein-protein interaction (PPI) network, miRNA-hub gene regulatory network and TF-hub gene regulatory network construction, and topological analysis were performed on the DEGs by the Gene Ontology (GO), REACTOME pathway, STRING, HiPPIE, miRNet, NetworkAnalyst and Cytoscape. Finally, we performed receiver operating characteristic curve (ROC) analysis of hub genes. A total of 930 DEGs 9464 up regulated genes and 466 down regulated genes) were identified in HF. GO and REACTOME pathway enrichment results showed that DEGs mainly enriched in localization, small molecule metabolic process, SARS-CoV infections and the citric acid (TCA) cycle and respiratory electron transport. Subsequently, the PPI network, miRNA-hub gene regulatory network and TF-hub gene regulatory network were constructed, and 10 hub genes in these network were focused on by centrality analysis and module analysis. Furthermore, data showed that HSP90AA1, ARRB2, MYH9, HSP90AB1, FLNA, EGFR, PIK3R1, CUL4A, YEATS4 and KAT2B were good diagnostic values. In summary, this study suggests that HSP90AA1, ARRB2, MYH9, HSP90AB1, FLNA, EGFR, PIK3R1, CUL4A, YEATS4 and KAT2B may act as the key genes in HF.

Heart failure (HF) is one of the chronic cardiovascular diseases, affecting 1% to 2% of the adult population worldwide [1] . HF is said to be inefficiency of the heart to supply the peripheral tissues with the appropriate amount of blood and oxygen to meet their metabolic requirement and is linked with a high risk for subsequent mortality and morbidity [2] . Multiple risk factors might cause HF, including diabetics [3] , hypertension [4] , obesity [5] , genetics [6] , environmental triggers [7] , and immunity, inflammation, and oxidative stress [8] . Although there are extensive investigation available regarding the etiologies and mechanisms underlying HF, the precise molecular mechanisms remain unclear [9] [10] . Therefore, essential molecular markers of HF that are identifiable with more powerful technologies are urgently required.

Understanding the status of various genes and signaling pathway in early diagnosis of HF could improve the effect of initial treatment. COL1A1 [11] , CXCL14 [12] , MECP2 [13] , RBM20 [14] , , Wnt signaling pathway [16] , TGF β 1/Smad3 signaling pathway [17] , AT1-CARP signaling pathway [18] , Akt signaling pathway [19] and neuregulin-1/ErbB signaling [20] were responsible for progression of HF. Therefore, we aimed to further explore the molecular pathogenesis of HF and identify specific molecular targets. However, these data still demand further clinical interpretation.

Next-generation sequencing (NGS) technology plays a crucial role in the analysis of gene expression, which served as important tools in cardiovascular research with great clinical application [21] . Recently, a large number of gene expression profiling studies have been reported with the use of NGS technology. The integrated bioinformatics analysis will be more positive and provide valuable novel molecular targets to foster the advancement of specific diagnosis and new therapeutic strategies. KAT2B (Fig. 7) . The AUCs for the 10 hub genes were 0. 953, 0.941, 0.976, 0.948, 0.931, 0.969, 0,958, 0.906, 0 .912 and 0.950, respectively. These hub genes show good diagnostics values.

Although many relevant investigation of HF have been operated, early diagnoses, adequacy of treatment and prognosis for HF remain poorly concluded. For diagnosis and treatment, it is vital to more interpret the molecular mechanisms resulting in occurrence and advancement. Bioinformatics analysis is progressively adopted to screen out biomarkers have a guiding role in the diagnosis and treatment of HF [37] .

In this investigation, we performed a series of bioinformatics analysis to screen key genes and pathways. The expression profiling by high throughput sequencing data found that 464 up regulated genes and 466 down regulated genes were identified in HF samples compared to normal control samples. ZFP57 [38] and ANK1 [39] contributes to the progression of diabetics, but these genes might be novel target for HF. TNC (tenascin C) has been shown to be activated in cardiac hypertrophy [40] . CCL2 is mainly involved in the progression of myocardial infarction [41] . SPP1[42] and IGSF1 [43] plays an important role in obesity, but these genes might be novel target for HF. Kiczak et al [44] found that TIMP1 was highly expressed in the HF. GO and REACTOME pathway enrichment analyses were used to investigate the interactions of these DEGs. SARS-CoV infections [45] , asparagine N-linked glycosylation [46] [76] , SLC16A9 [77] , ACADSB (acyl-CoA dehydrogenase short/branched chain) [78] , IMPA1 [79] , CD300LG [80] , CIRBP (cold inducible RNA binding protein) [81] , PIK3R1 [82] , YEATS4 [83] , USP2 [84] , NEDD9 [85] , CHCHD5 [86] and ERAP1 [87] promotes hypertension. HSPB1 [88] , CRYAB (crystallin alpha B) [89] , ANXA5 [90] , CCR2 [91] RGN (regucalcin) [105], PPA2 [106] , KAT2B [107] , PDK1 [108] , CS (citrate synthase) [109] , FGF12 [110] , AQP4 [111] , LMOD2 [112] , SELENBP1 [113] , MB (myoglobin) [114] , S100A1 [115] , RYR2 [116] , GPC5 [117] mitochondrial) [184], MGST3 [185] , COQ7 [186] , ACSL5 [187] , ANK1 [188] , PYGM (glycogen phosphorylase, muscle associated) [189] , FBXO40 [190] , SLC2A4 [191] , , TAP2 [193] , , NSMCE2 [195] , NDUFA4 [196] , HMG20A [197] , AMY2B [198] and ACYP2 [199] might be involved in the pathogenesis of diabetics, but these genes might be novel target for HF. Recent evidence indicates that the SIRPA (signal regulatory protein alpha) [200] , PFN1 [201] , EIF6 [202] , AHR (aryl hydrocarbon receptor) [203] , RUNX1 [204] , IDO1 [205] , PDHB (pyruvate dehydrogenase E1 subunit beta) [206] , NDUFS1 [207] , MTUS1 [208] , ZNF418 [209] and MTMR14 [210] [246] were reported to be expressed in obesity, but these genes might be novel target for HF. TGFB1 [247] , CD63 [248] , DACT1 [249] and PSMB10 [250] have been reported to be crucial for the progression of atrial fibrillation. FAM20C [251] and CD74 [252] are important in the development of cardiac arrhythmia.

To explore the pathogenesis of HF, we constructed PPI network and isolated modules from PPI network for systematic analysis. The genes in the PPI network and modules with higher score were the hub genes that affected the progression of disease. CLTA (clathrin light chain A), RAI14, MPRIP (myosin phosphatase Rho interacting protein), AP2A1, CUL4A and NDUFA13 were the novel biomarkers for the progression of HF.

We further constructed a miRNA-hub gene regulatory network and TF-hub gene regulatory network for better understanding of the interaction between miRNA and hub genes, and TF and hub genes. , hsa-mir-539-5p [254] and RUNX1T1 [255] were linked with progression of obesity, but these genes might be novel target for HF. and STAT1 [257] were involved in the progression of HF. and STAT5B [259] were associated with development of diabetics, but these genes might be novel target for HF. EGR1 [260] and GATA2 [261] were liable for advancement of coronary heart disease. FOSB [262] and AHR [263] were associated with development of ischemic cardiac diseases. TWIST1 was responsible for progression of atherosclerosis [264] . TUBB (tubulin beta class I), hsa-mir-520e, hsa-mir-8084, hsa-mir-133a-3p, hsa-mir-4801, hsa-mir-132-3p, hsa-mir-449a, ARNT, and GTF2H1 were the novel biomarkers for the progression of HF.

In summary, the present data provide a comprehensive bioinformatics analysis of DEGs that might be related to the progression of HF. We have identified 930 candidate DEGs with NGS data and integrated bioinformatics analyses. A variety of novel genes and signaling pathways might be associated in the pathogenesis of HF. We also conclude that HSP90AA1, ARRB2, MYH9, HSP90AB1, FLNA, EGFR, PIK3R1, CUL4A, YEATS4 and KAT2B might be associated with progression of HF. These findings could lead to an increase in our understanding of the etiology and underlying molecular events of HF. Choudhury A, Chung I, Blann AD, Lip GY. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm. J Am Coll Cardiol. 2007; 49(19):1957 -1964 Fig. 1 . Volcano plot of differentially expressed genes. Genes with a significant change of more than two-fold were selected. Green dot represented up regulated significant genes and red dot represented down regulated significant genes. 

Risk stratification in heart failure: Existing challenges and potential promise

Diabetes as a risk factor for heart failure in women and men: a systematic review and metaanalysis of 47 cohorts including 12 million individuals

Plekha7 attenuates salt-sensitive hypertension in the rat

Renal tubule angiotensin II type 1 receptor-associated protein promotes natriuresis and inhibits salt-sensitive blood pressure elevation

Gene-alcohol interactions identify several novel blood pressure loci including a promising locus near SLC16A9

Association of genetic polymorphisms of ACADSB and COMT with human hypertension

Inositol monophosphatase 1 as a novel interacting partner of RAGE in pulmonary hypertension

Blood pressure levels in male carriers of Arg82Cys in CD300LG

Deficiency of cold-inducible RNAbinding protein exacerbated monocrotaline-induced pulmonary artery hypertension through Caveolin1 and CAVIN1

Knockdown of PIK3R1 by shRNA inhibits the activity of the splenic macrophages associated with hypersplenism due to portal hypertension

Multi-Institutional Implementation of Clinical Decision Support for APOL1, NAT2, and YEATS4 Genotyping in Antihypertensive Management

Mice carrying ubiquitin-specific protease 2 (Usp2) gene inactivation maintain normal sodium balance and blood pressure

NEDD9, a Hypoxia-upregulated Mediator for Pathogenic Platelet-Endothelial Cell Interaction in Pulmonary Hypertension

A new risk locus in CHCHD5 for hypertension and obesity in a Chinese child population: a cohort study

Gene Variation of Endoplasmic Reticulum Aminopeptidases 1 and 2, and Risk of Blood Pressure Progression and Incident Hypertension among 17,255 Initially Healthy Women

Protective effect of geranylgeranylacetone via enhanced induction of HSPB1 and HSPB8 in mitochondria of the failing heart following myocardial infarction in rats

BYD Ameliorates Oxidative Stress-Induced Myocardial Apoptosis in Heart Failure Post-Acute Myocardial Infarction via the P38 MAPK-CRYAB Signaling Pathway

Circulating annexin A5 predicts mortality in patients with heart failure

Chemokine receptor (CCR2)

Long-read sequencing identified a novel nonsense and a de novo missense of PPA2 in trans in a Chinese patient with autosomal recessive infantile sudden cardiac failure

Identification of epigenetic factor KAT2B gene variants for possible roles in congenital heart diseases

Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia

Respiratory Muscle Training Improves Diaphragm Citrate Synthase Activity and Hemodynamic Function in Rats with Heart Failure

De Novo FGF12 (Fibroblast Growth Factor 12) Functional Variation Is Potentially Associated With Idiopathic Ventricular Tachycardia

AQP4-knockout aggravation of isoprenaline-induced myocardial injury is mediated by p66Shc and endoplasmic reticulum stress

Cardiac-specific knockout of Lmod2 results in a severe reduction in myofilament force production and rapid cardiac failure

Circulating levels of selenium-binding protein 1 (SELENBP1) are associated with risk for major adverse cardiac events and death

Signal regulatory protein-α protects against cardiac hypertrophy via the disruption of toll-like receptor 4 signaling

Downregulation of Profilin-1 Expression Attenuates Cardiomyocytes Hypertrophy and Apoptosis Induced by Advanced Glycation End Products in H9c2 Cells

Characterizing the role of endothelin-1 in the progression of cardiac hypertrophy in aryl hydrocarbon receptor (AhR) null mice

Runt-related transcription factor 1 (Runx1) aggravates pathological cardiac hypertrophy by promoting p53 expression

3-Dioxygenase 1 (IDO1) Promotes Cardiac Hypertrophy via a PI3K-AKT-mTOR-Dependent Mechanism

Comparative Proteome Profiling during Cardiac Hypertrophy and Myocardial Infarction Reveals Altered Glucose Oxidation by Differential Activation of Pyruvate Dehydrogenase E1 Component Subunit 3

CC membrane 1.92278E-06 5.716070067 279 TNC

FRMPD1,RASAL2,ZNF4 83,NDUFA2,ZNF160,FBXL 17,BORCS7,COX7B,SDHB ,AFG3L2,ZNF25,NDUFA4, FUNDC1,TRAK1

R-HSA-6798695 Neutrophil degranulation 0.005152656 2.287968817 30 RNASE2

Down regulated genes REAC:R-HSA-1428517 The citric acid (TCA) cycle and respiratory electron transport 1.59E-19 18.7992737 34 COQ10A,NDUFA1

R-HSA-913531 Interferon Signaling 0.000694263 3.158475852 16 GBP4,GBP1,TRIM22,I`FIT 3,IRF6